Leuprolide Acetate Maintains Functional Capabilities In Women With Alzheimer's Disease

Leuprolide Acetate Maintains Functional Capabilities In Women With Alzheimer's Disease: "Women with mild to moderate Alzheimer's disease who are treated with the investigational hormone drug leuprolide acetate and conventional therapy with acetylcholinesterase inhibitors (AChEI) seem to maintain their cognitive and physical function longer than women treated with AChEI therapy alone, according to phase II results released at the Tenth International Conference on Alzheimer's Disease and Related Disorders (ICAD). "